⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SRPT News
Sarepta Therapeutics,, Inc. Common Stock
Oligonucleotides Global Markets, 2022-2024 & 2025-2030, Profiles of Major Players - Alnylam Pharmaceuticals, Biogen/Ionis Pharmaceuticals, Novartis, and Sarepta Therapeutics
globenewswire.com
ALNY
SRPT
IONS
JAZZ
Sarepta Therapeutics Announces Call for Applications for the 9 th Annual Route 79, The Duchenne Scholarship Program
businesswire.com
SRPT
Sarepta Therapeutics anuncia la convocatoria de solicitudes para la 9º edición anual de Route 79, el programa de becas de Duchenne
businesswire.com
SRPT
Sarepta Therapeutics to Present New Long-Term and Safety Data Across Gene Therapy and Exon-Skipping Programs at 2026 Muscular Dystrophy Association Clinical & Scientific Congress
businesswire.com
SRPT
Form 8-K
sec.gov
SRPT
Form 8-K
sec.gov
SRPT
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments
businesswire.com
SRPT
MIPI Alliance發表UniPro v3.0和M-PHY v6.0，協助提升行動裝置、PC和汽車領域邊緣AI的JEDEC UFS效能
businesswire.com
GOOGL
QCOM
TXN
MU
INTC
AAPL
MSFT
NVDA
AMZN
ADI
NXPI
STM
ON
AMD
MRVL
AVGO
MCHP
WDC
SE
SMTC
SNPS
AMKR
ALGN
ASML
CDNS
CHKP
CRUS
DLTR
ENPH
ERIC
FSLR
GILD
HPE
IBM
INFY
INTU
KEYS
KHC
LRCX
LULU
MDT
MELI
MNST
MRNA
MSI
NFLX
NTAP
ORCL
PAYX
PEP
PPC
PYPL
REGN
ROST
SBUX
SIRI
SNOW
SRPT
SWKS
TCOM
TDS
TECK
TER
TGT
TMO
TSLA
TTWO
ULTA
VRSK
VRTX
WEC
XEL
XRAY
ZBRA
ZM
ZS
Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan
businesswire.com
SRPT
Sarepta Therapeutics to Present at the TD Cowen 46 th Annual Health Care Conference
businesswire.com
SRPT